The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $0.95

Today's change-0.04 -3.95%
Updated September 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $0.95

Today's change-0.04 -3.95%
Updated September 20 4:00 PM EDT. Delayed by at least 15 minutes.

VIVUS Inc down (U.S.)$0.04

VIVUS Inc closed sharply lower Wednesday, dropping (U.S.)$0.04 or 3.95% to (U.S.)$0.95. Although unchanged over the last five days, shares are down 17.48% for the last year to date. This security has underperformed the S&P 500 by 27.69% during the last year.

Key company metrics

  • Open(U.S.) $0.98
  • Previous close(U.S.) $0.99
  • High(U.S.) $0.99
  • Low(U.S.) $0.95
  • Bid / Ask(U.S.) $0.81 / (U.S.) $1.09
  • YTD % change-17.48%
  • Volume891,429
  • Average volume (10-day)954,430
  • Average volume (1-month)939,273
  • Average volume (3-month)901,311
  • 52-week range(U.S.) $0.86 to (U.S.) $1.47
  • Beta0.94
  • Trailing P/E3.13×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.30
Updated September 20 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+24.71%

Based on its net profit margin of 24.71%, VIVUS Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.63%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue11278213
Total other revenue--------
Total revenue11278213
Gross profit8218011
Total cost of revenue4622
Total operating expense16201714
Selling / general / administrative12111310
Research & development1222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----0--
Other operating expenses, total--------
Operating income-5765-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-13-157-9
Income after tax-13-157-9
Income tax, total0000
Net income-13-157-9
Total adjustments to net income--------
Net income before extra. items-13-157-9
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-157-9
Inc. avail. to common incl. extra. items-13-157-9
Diluted net income-13-157-9
Dilution adjustment0--0--
Diluted weighted average shares106105107104
Diluted EPS excluding extraordinary itemsvalue per share-0.13-0.010.53-0.09
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.13-0.010.53-0.09